{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:48:10Z","timestamp":1774594090010,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011785","name":"Science and Technology Department of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["AD25069077\u00a0AD25069077\u00a0\u591a\u6a21\u578b\u7ffb\u8bd1\u5bf9\u6bd4"],"award-info":[{"award-number":["AD25069077\u00a0AD25069077\u00a0\u591a\u6a21\u578b\u7ffb\u8bd1\u5bf9\u6bd4"]}],"id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Brainstem glioma (BSG) is a rare neoplasm characterized by short survival and high mortality. Thus far, treatment efficacy for this tumor has remained limited, highlighting the critical demand for novel and effective therapeutic strategies. The utilization of CyberKnife Stereotactic Radiation Therapy(CyberKnife-SRT) for BSG may render favorable outcomes. Nevertheless, robust clinical data remain limited at present. Therefore, this study was designed to assess the efficacy and safety of CyberKnife-SRT in the treatment of BSG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted using clinical data from patients treated with CyberKnife-SRT for BSG between August 2009 and July 2024. Demographic characteristics and treatment parameters were extracted. Overall Survival (OS) was defined as the interval from initial diagnosis to death from any cause or the last follow-up; survival curves were estimated with the Kaplan\u2013Meier method, and inter-group differences were evaluated using the Log-rank (Mantel-Cox) test. Univariate Cox proportional-hazards models were fitted to assess the association between each candidate variable and the risk of death. Subsequently, variables were selected by backward stepwise elimination based on Akaike\u2019s information criterion (AIC), and a multivariate Cox proportional-hazards model was constructed to identify factors independently associated with mortality. And the incidence of adverse reactions of the patients were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 54 BSG patients treated with CyberKnife-SRT were enrolled, with a median follow-up of 71 months (Range: 3.03 - 182.97 months). Median Overall Survival (mOS) for the entire cohort was 20.9 months (95% CI 15.7 - 67.6). Median Progression-free Survival (mPFS) was 13.7 months(95% CI 8.83 - 20.08). The 1-year and 5-year OS rates were 83.39% and 32.74%, respectively. The 1-year and 5-year PFS rates were 57.02% and 21.36%. Univariate Cox regression analysis revealed that tumor volume &amp;gt; 8 cm\u00b3 (HR 3.04, 95% CI 1.61 - 7.97, p = 0.024), age 3\u201317 years (HR 2.27, 95% CI 1.04 - 4.96, p = 0.039), and age 51\u201369 years (HR 5.47, 95% CI 1.76 - 17.02, p = 0.003) were significantly associated with an increased risk of death, whereas Karnofsky Performance Status (KPS) score \u2265 70 was the only protective factor identified (HR 0.39, 95% CI 0.19 - 0.82, p = 0.013), while surgery, chemotherapy and targeted therapy had no significant impact. Multivariate Cox regression analysis showed that, compared with the 18\u201350-year age group, the 51 - 69-year age group had a significantly higher risk of death (HR = 6.69, 95% CI 2.03-22.00, p = 0.002). Regarding safety, 17 (31.48%) patients developed radiation-induced brain edema, and 4 (7.41%) patients had obstructive hydrocephalus. All conditions improved after active treatment. No radiation necrosis or radiotherapy-related deaths were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Indirect comparison with historically reported data indicates that CyberKnife-SRT is associated with prolonged survival in patients with BSG, with manageable treatment-related toxicities. These results suggest a favorable benefit-risk profile for CyberKnife-SRT in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1730758","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:19:28Z","timestamp":1774588768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation on the efficacy and safety of CyberKnife stereotactic radiotherapy for brainstem gliomas"],"prefix":"10.3389","volume":"16","author":[{"given":"Penghui","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Department of Radiation Oncology, The Third Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guimei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchao","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, Guangxi, China"]},{"name":"Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","place":["Nanning, Guangxi, China"]},{"name":"Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases","place":["Nanning, Guangxi, China"]},{"name":"State Key Laboratory of Targeting Oncology, Guangxi Medical University","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuping","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine","place":["Nanning, Guangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1227\/00006123-199312000-00010","article-title":"Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group","volume":"33","author":"Albright","year":"1993","journal-title":"Neurosurgery"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.3390\/curroncol30110709","article-title":"Surgical Management of Adult Brainstem Gliomas: A Systematic Review and Meta-Analysis","volume":"30","author":"Ius","year":"2023","journal-title":"Curr Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4143\/crt.2005.37.2.109","article-title":"Outcome and prognostic factors of childhood diffuse brainstem glioma","volume":"37","author":"Hong","year":"2005","journal-title":"Cancer Res Treat"},{"key":"B6","doi-asserted-by":"publisher","first-page":"103508","DOI":"10.1016\/j.critrevonc.2021.103508","article-title":"Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors","volume":"168","author":"Gagliardi","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajo.2022.12.021","article-title":"Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma","volume":"250","author":"Liegl","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S0360-3016(25)00066-5","DOI":"10.1016\/j.ijrobp.2025.01.014","article-title":"Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study","volume":"23","author":"Ratnakumaran","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.ijrobp.2020.11.036","article-title":"Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking","volume":"109","author":"Zhang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"B11","article-title":"Common terminology criteria for adverse events (CTCAE) v4.0","author":"National Cancer Institute","year":"2009","journal-title":"U.S. Department of Health and Human Services, National Institutes of Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11060-019-03313-w","article-title":"Association between extent of resection on survival in adult brainstem high-grade glioma patients","volume":"145","author":"Doyle","year":"2019","journal-title":"J Neurooncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3171\/2023.7.PEDS22462","article-title":"Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review","volume":"32","author":"Dalmage","year":"2023","journal-title":"J Neurosurg Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijrobp.2022.01.054","article-title":"Hypofractionated Radiation Therapy For Diffuse Intrinsic Pontine Glioma: A Noninferiority Randomized Study Including 253 Children","volume":"113","author":"Zaghloul","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3988\/jcn.2021.17.2.220","article-title":"Clinical and Genetic Features of Brainstem Glioma in Adults: A Report of 50 Cases in a Single Center","volume":"17","author":"Zhou","year":"2021","journal-title":"J Clin Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00415-021-10725-0","article-title":"Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature","volume":"269","author":"Leibetseder","year":"2022","journal-title":"J Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0360-3016(92)90704-l","article-title":"Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults","volume":"24","author":"Shrieve","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/s0360-3016(98)00501-x","article-title":"There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy","volume":"43","author":"Mandell","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2014.01.013","article-title":"Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial","volume":"111","author":"Zaghloul","year":"2014","journal-title":"Radiother Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00257","article-title":"Clinical efficacy of cyberKnife radiosurgery for adult brainstem glioma: 10 years experience at tianjin cyberKnife center and review of the literature","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/ijc.35218","article-title":"A phase I clinical trial of sonodynamic therapy combined with radiotherapy for brainstem gliomas","volume":"156","author":"Huangfu","year":"2025","journal-title":"Int J Can"},{"key":"B23","doi-asserted-by":"publisher","first-page":"105296","DOI":"10.1016\/j.pdpdt.2025.105296","article-title":"Sonodynamic therapy with chemo-radiotherapy in high-grade brainstem gliomas: A prospective phase IIa clinical trial","volume":"57","author":"Liu","year":"2026","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-025-62260-5","article-title":"The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials","volume":"16","author":"Qian","year":"2025","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/neuonc\/noaf039","article-title":"Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma","volume":"27","author":"Souweidane","year":"2025","journal-title":"Neuro Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1730758\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:19:29Z","timestamp":1774588769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1730758\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":25,"alternative-id":["10.3389\/fonc.2026.1730758"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1730758","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1730758"}}